Page last updated: 2024-08-17

cysteamine and Parkinson Disease, Secondary

cysteamine has been researched along with Parkinson Disease, Secondary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, EH; Cho, SW; Choi, SY; Eum, WS; Hwang, JH; Jeong, HJ; Kang, HW; Kang, TC; Kim, DS; Kim, DW; Kim, MJ; Kwon, OS; Lee, YP; Park, J; Shin, MJ; Sohn, EJ1

Other Studies

1 other study(ies) available for cysteamine and Parkinson Disease, Secondary

ArticleYear
PEP-1-heat shock protein 27 protects from neuronal damage in cells and in a Parkinson's disease mouse model.
    The FEBS journal, 2012, Volume: 279, Issue:11

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Cell Death; Cell Line, Tumor; Cysteamine; DNA Fragmentation; Dopaminergic Neurons; Escherichia coli; HSP27 Heat-Shock Proteins; Humans; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Parkinson Disease, Secondary; Peptides; Reactive Oxygen Species; Recombinant Fusion Proteins; Rotarod Performance Test; Substantia Nigra

2012